ERBB2 and neoplasm: Interestingly, the infusion of these macrophages significantly inhibited tumor growth with HER2-positive expression in vivo, along with degrading the matrix and promoting T-cell infiltration into tumors, highlighting that targeting the ECM by engineered macrophages could be an effective strategy to augment CAR T cell infiltration into solid tumors (74).